Literature DB >> 6932931

The radiosensitivity of a murine fibrosarcoma as measured by three cell survival assays.

L Rice, M Urano, H D Suit.   

Abstract

The radiation sensitivity of a weakly immunogenic spontaneous fibrosarcoma of the C3Hf/Sed mouse (designated FSa-II) was assessed by three in vivo cell survival methods: end-point dilution (TD50) assay, lung colony (LC) assay, and agar diffusion chamber (ADC) assay. The hypoxic fraction of this tumour was also determined by the ADC method. Although there was a good agreement of the cell survival data between the ADC and LC methods, the TD50 method yielded a considerably less steep cell survival curve. Beneficial aspects and limitations of each assay are discussed. In addition, the use of the ADC method for the growth of xenogeneic cell lines and a preliminary experiment with human tumour cells in non-immunosuppressed hosts suggest that this method may be a valuable adjunct for studying the growth and therapeutic responses of human tumour cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932931      PMCID: PMC2149250     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  13 in total

1.  Letter: A comparison of the radiosensitivity and o.e.r. of human and mouse marrow progenitor cells cultured in agar in diffusion chambers.

Authors:  M Y Gordon
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1975-09

2.  In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft.

Authors:  V D Courtenay; I E Smith; M J Peckham; G G Steel
Journal:  Nature       Date:  1976-10-28       Impact factor: 49.962

3.  Changes in proliferation rate of human bone marrow colony-forming cells measured by a cytosine arabinoside-diffusion chamber method.

Authors:  M Y Gordon; I D Douglas
Journal:  Eur J Cancer       Date:  1976-07       Impact factor: 9.162

4.  Proliferative properties of malignant cell populations cultured in intraperitoneal diffusion chambers.

Authors:  O D Laerum; A Grüneisen; M F Rajewsky
Journal:  Eur J Cancer       Date:  1973-08       Impact factor: 9.162

5.  A cesium-137 irradiator for small laboratory animals.

Authors:  E B Hranitzky; P R Almond; H D Suit; E B Moore
Journal:  Radiology       Date:  1973-06       Impact factor: 11.105

6.  A lung-colony assay to determine the radiosensitivity of cells of a solid tumour.

Authors:  R P Hill; R S Bush
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1969-07

7.  Survival curves for clonogenic cells of a murine keratinizing squamous carcinoma irradiated in vivo or under hypoxic conditions.

Authors:  H B Hewitt; D P Chan; E R Blake
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1967

8.  Immunologic status of host and response of a methylcholanthrene-induced sarcoma to local x-irradiation.

Authors:  H D Suit; A Kastelan
Journal:  Cancer       Date:  1970-07       Impact factor: 6.860

9.  The sensitivities of human and murine hemopoietic cells exposed to cytotoxic drugs in an in vivo culture system.

Authors:  M Y Gordon; N Blackett
Journal:  Cancer Res       Date:  1976-08       Impact factor: 12.701

10.  Quantitation of haemopoietic cells from normal and leukaemic RFM mice using an in vivo colony assay.

Authors:  M Y Gordon
Journal:  Br J Cancer       Date:  1974-11       Impact factor: 7.640

View more
  16 in total

1.  Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.

Authors:  G N Schwartz; B A Teicher; J P Eder; T Korbut; S A Holden; G Ara; T S Herman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.

Authors:  B A Teicher; S A Holden; G Ara; C S Ha; T S Herman; D Northey
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.

Authors:  T S Herman; B A Teicher; M R Pfeffer; V S Khandekar; E Alvarez Sotomayor
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 4.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.

Authors:  B A Teicher; T S Herman; J Tanaka; B Dezube; A Pardee; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.

Authors:  B A Teicher; T S Herman; S A Holden; K N Cathcart
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

7.  Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.

Authors:  B A Teicher; S D Bernal; S A Holden; K N Cathcart
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  CAI: effects on cytotoxic therapies in vitro and in vivo.

Authors:  B A Teicher; S A Holden; Y N Chen; G Ara; T T Korbut; D Northey
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  A preclinical model for sequential high-dose chemotherapy.

Authors:  S A Holden; B A Teicher; L J Ayash; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

10.  Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.

Authors:  B A Teicher; T S Herman; R E Hopkins; K Menon
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.